The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Inflammasome Priming in Sterile Inflammatory Disease
Abstract
The inflammasome is a cytoplasmic protein complex that processes interleukins (IL)-1β and IL-18, and drives a form of cell death known as pyroptosis. Oligomerization of this complex is actually the second step of activation, and a priming step must occur first. This involves transcriptional upregulation of pro-IL-1β, inflammasome sensor NLRP3, or the non-canonical inflammasome sensor caspase-11. An additional aspect of priming is the post-translational modification of particular inflammasome constituents. Priming is typically accomplished in vitro using a microbial Toll-like receptor (TLR) ligand. However, it is now clear that inflammasomes are activated during the progression of sterile inflammatory diseases such as atherosclerosis, metabolic disease, and neuroinflammatory disorders. Therefore, it is time to consider the endogenous factors and mechanisms that may prime the inflammasome in these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The functional regulation of an active NLRP3 inflammasome in a cell is a ‘two-hit’ process, in which signal 1 primes the transcription of the inflammasome and signal 2, either by the same and/or additional stimuli, activates the inflammasome and induces secretion of two pro-inflammatory cytokines, IL-1β and IL-18 (REFS63,64).”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
Moon, J.-S., Hisata, S., Park, M. A., DeNicola, G. M., Ryter, S. W., Nakahira, K., & Choi, A. M. K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.046 · Cited by 379
RetractedUCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis
Moon, J.-S., Lee, S., Park, M.-A., Siempos, I. I., Haslip, M., Lee, P. J., Yun, M., Kim, C. K., Howrylak, J., Ryter, S. W., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78253 · Cited by 238
RetractedA role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Self-citationNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Inflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340
Bauernfeind, F. G., Horvath, G. L., Stutz, A., Alnemri, E. S., MacDonald, K. L., Speert, D. P., Fernandes‐Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 3,087
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Flagged first, then by citations
Research works printed but not linked: 4
- Panchanathan, 2016, Hypoxia primes human normal prostate epithelial cells and cancer cell lines for the NLRP3 and AIM2 inflammasome activation, Oncotarget, 7, 28183, 10.18632/oncotarget.8594 · DOI
- Masters, 2010, Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes, Nat. Immunol., 11, 897, 10.1038/ni.1935 · DOI · Paper page
- Duewell, 2010, NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals, Nature, 464, 1357, 10.1038/nature08938 · DOI · Paper page
- Juliana, 2012, Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation, J. Biol. Chem., 287, 36617, 10.1074/jbc.M112.407130 · DOI
Cited by
Sorted by citations
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
Libby, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.028 · Cited by 651
Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases
Grazioli, S., & Pugin, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00832 · Cited by 429
Han, X., Sun, S., Sun, Y., Song, Q., Zhu, J., Song, N., Chen, M., Sun, T., Xia, M., Ding, J., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1596481 · Cited by 408
Zhang, Y., Liu, X., Bai, X., Yuan, L., Li, Z., Fu, J., Li, M., Zhao, T., Yang, H., Xu, R., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12449 · Cited by 395
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387
LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury
Wan, P., Su, W., Zhang, Y., Li, Z., Deng, C., Li, J., Jiang, N., Huang, S., Long, E., & Zhuo, Y. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0351-4 · Cited by 289
Inflammasomes in Tissue Damages and Immune Disorders After Trauma
Bortolotti, P., Faure, E., & Kipnis, É. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01900 · Cited by 268
Wooff, Y., Man, S. M., Aggio‐Bruce, R., Natoli, R., & Fernando, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01618 · Cited by 250
The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins
Deora, V., Lee, J. D., Albornoz, E. A., McAlary, L., Jagaraj, C. J., Robertson, A. A. B., Atkin, J. D., Cooper, M. A., Schroder, K., Yerbury, J. J., et al. (2020) · Glia · doi:10.1002/glia.23728 · Cited by 245
NLRP3 inflammasome priming: A riddle wrapped in a mystery inside an enigma
McKee, C. M., & Coll, R. C. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0720-513r · Cited by 246
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
Hamarsheh, S., & Zeiser, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01444 · Cited by 233
The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target
O’Brien, W. T., Pham, L., Symons, G. F., Monif, M., Shultz, S. R., & McDonald, S. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01778-5 · Cited by 233
Microglia and CNS Interleukin-1: Beyond Immunological Concepts
Liu, X., & Quan, N. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00008 · Cited by 221
The role of inflammasomes in vascular cognitive impairment
Poh, L., Sim, W. L., Jo, D., Dinh, Q. N., Drummond, G. R., Sobey, C. G., Chen, C., Lai, M. K. P., Fann, D. Y., & Arumugam, T. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00506-8 · Cited by 167
NLRP3 inflammasome activation in inflammaging
Latz, E., & Duewell, P. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.001 · Cited by 174
Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
Gritsenko, A., Yu, S., Martín‐Sánchez, F., Diaz-del-Olmo, I., Nichols, E.-M., Davis, D. M., Brough, D., & López‐Castejón, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565924 · Cited by 173
The P2X7 Receptor Primes IL-1β and the NLRP3 Inflammasome in Astrocytes Exposed to Mechanical Strain
Albalawi, F., Lu, W., Beckel, J. M., Lim, J. C., McCaughey, S. A., & Mitchell, C. H. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00227 · Cited by 155
NLRP3 inflammasome in neurodegenerative disease
Anderson, F. L., Biggs, K. E., Rankin, B. E., & Havrda, M. C. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.006 · Cited by 154
IKKβ primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network
Schmacke, N. A., O’Duill, F., Gaidt, M. M., Szymanska, I., Kamper, J. M., Schmid-Burgk, J. L., Mädler, S. C., Mackens‐Kiani, T., Kozaki, T., Chauhan, D., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.021 · Cited by 136
Sand, J., Haertel, E., Biedermann, T., Contassot, E., Ernst Reichmann, A., French, L. E., Werner, S., & Beer, H. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0009-4 · Cited by 130
Gasdermin D mediates the maturation and release of IL-1α downstream of inflammasomes
Tsuchiya, K., Hosojima, S., Hara, H., Kushiyama, H., Mahib, M. R., Kinoshita, T., & Suda, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108887 · Cited by 137
Zhang, Q., Sun, J., Wang, Y., He, W., Wang, L., Zheng, Y., Wu, J., Zhang, Y., & Jiang, X. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02142 · Cited by 124
Interaction between autophagy and the NLRP3 inflammasome
Cao, Z., Wang, Y., Long, Z., & He, G. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz098 · Cited by 119
The Nlrp3 inflammasome as a “rising star” in studies of normal and malignant hematopoiesis
Ratajczak, M. Z., Bujko, K., Cymer, M., Thapa, A., Adamiak, M., Ratajczak, J., Abdel-Latif, A. K., & Kucia, M. (2020) · Leukemia · doi:10.1038/s41375-020-0827-8 · Cited by 102
Yang, M., Lv, H., Liu, Q., Zhang, L., Zhang, R., Huang, X., Wang, X., Han, B., Hou, S., Liu, D., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9173530 · Cited by 100
Jiang, Y., Liu, H., Yu, H., Zhou, Y., Zhang, J., Xin, W., Li, Y., He, S., Ma, C., Zheng, X., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315525 · Cited by 100
Deng, X., Huang, W., Peng, J., Zhu, T., Sun, X.-L., Zhou, X.-Y., Yang, H., Xiong, J., He, H.-Q., Xu, Y.-H., et al. (2017) · Inflammation · doi:10.1007/s10753-017-0685-3 · Cited by 92
Inflammasome activation and Th17 responses
Deng, J. P., Yu, X., & Wang, P. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.024 · Cited by 94
The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways
Jiang, D., Chen, S., Sun, R., Zhang, X., & Wang, D. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.034 · Cited by 95
Stødle, G. S., da Silva, G. B., Tangerås, L. H., Gierman, L. M., Nervik, I., Dahlberg, U. E., Sun, C., Aune, M. H., Thomsen, L. C. V., Bjørge, L., et al. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13130 · Cited by 93
Circulating mitochondria in organ donors promote allograft rejection
Lin, L., Xu, H., Bishawi, M. M., Feng, F., Samy, K. P., Truskey, G. A., Barbas, A. S., Kirk, A. D., & Brennan, T. V. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15309 · Cited by 91
Lipid and Non-lipid Factors Affecting Macrophage Dysfunction and Inflammation in Atherosclerosis
Gibson, M. S., Domingues, N. S., & Vieira, O. V. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00654 · Cited by 82
Pirzada, R. H., Javaid, N., & Choi, S. (2020) · Genes · doi:10.3390/genes11020131 · Cited by 84
Zhao, P., Yin, S., Qiu, Y., Sun, C., & Yu, H. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02217-2 · Cited by 102
Shridas, P., de Beer, M. C., & Webb, N. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002428 · Cited by 84
Eren, E., Tüfekçi, K. U., Isci, K. B., Tastan, B., Genç, K., & Genç, Ş. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00036 · Cited by 84
Kovács, Z., D’Agostino, D. P., Diamond, D. M., Kindy, M. S., Rogers, C. Q., & Ari, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00363 · Cited by 87
Pan, H., Lin, Y., Dou, J., Fu, Z. F., Yao, Y., Ye, S., Zhang, S., Wang, N., Liu, A., Li, X., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12868 · Cited by 81
Oseni, S. O., Naar, C., Pavlović, M. D., Asghar, W., Hartmann, J. X., Fields, G. B., Esiobu, N., & Kumi-Diaka, J. K. (2023) · Cancers · doi:10.3390/cancers15123110 · Cited by 100
Rajan, T. S., Giacoppo, S., Diomede, F., Bramanti, P., Trubiani, O., & Mazzon, E. (2017) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632017722332 · Cited by 80
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Filipi, T., Heřmanová, Z., Turečková, J., Vaňátko, O., & Anděrová, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010261 · Cited by 76
The selective Nlrp3 inflammasome inhibitor Mcc950 attenuates lung ischemia-reperfusion injury
Xu, K., Wu, C., Tong, S., Peng, X., & Wang, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.089 · Cited by 75
Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction
Takahashi, M. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000709 · Cited by 77
Hadri, K. E., Smith, R., Duplus, E., & Amri, C. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010077 · Cited by 71
Frame, J. M., Kubaczka, C., Long, T. L., Esain, V., Soto, R. A., Hachimi, M., Jing, R., Shwartz, A., Goessling, W., Daley, G. Q., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.07.015 · Cited by 68
Kovács, Z., Brunner, B., & Ari, C. (2021) · Nutrients · doi:10.3390/nu13072197 · Cited by 68
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
Pavillard, L. E., Marín‐Aguilar, F., Bullón, P., & Cordero, M. D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.018 · Cited by 67
Inflammatory Diseases and Vitamin E—What Do We Know and Where Do We Go?
Wallert, M., Börmel, L., & Lorkowski, S. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000097 · Cited by 68
Wang, Z., Zhang, A., Meng, W., Wang, T., Li, D., Liu, Z., & Liu, H. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.059 · Cited by 61
Zhu, J., Chen, H., Le, Y., Guo, J., Liu, Z., Dou, X., & Lu, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1009229 · Cited by 63
Wang, X., Chi, J., Huang, D., Ding, L., Zhao, X., Jiang, L., Yu, Y., & Gao, F. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8297 · Cited by 61
NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction
Sokolova, M., Sahraoui, A., Høyem, M., Øgaard, J., Lien, E., Aukrust, P., Yndestad, A., Ranheim, T., & Scholz, H. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00461.2017 · Cited by 61
Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation
Wen, J., Chang, Y., Huo, S., Li, W., Huang, H., Gao, Y., Lin, H., Zhang, J., Zhang, Y., Zuo, Y., et al. (2020) · Aging · doi:10.18632/aging.202202 · Cited by 61
Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update
Yu, Q., Zhao, T., Liu, M., Cao, D., Li, J., Li, Y., Xia, M., Wang, X., Zheng, T., Liu, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.707696 · Cited by 61
Alves, J. V., da Costa, R. M., Pereira, C. A., Fedoce, A. G., Silva, C. A. A., Carneiro, F. S., Lobato, N. S., & Tostes, R. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01647 · Cited by 62
Nuclear Receptors as Multiple Regulators of NLRP3 Inflammasome Function
Alatshan, A., & Benkő, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630569 · Cited by 58
Alcohol accumulation promotes esophagitis via pyroptosis activation
Wang, F., Li, G., Ning, J., Chen, L., Xu, H., Kong, X., Bu, J., Zhao, W., Li, Z., Wang, X., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24347 · Cited by 54
Role of Perinatal Inflammation in Neonatal Arterial Ischemic Stroke
Giraud, A., Guiraut, C., Chevin, M., Chabrier, S., & Sébire, G. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00612 · Cited by 58
Jan, S. L., Muller, C. B., Plée, J., Durlach, A., Bernard, P., & Antonicelli, F. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01972 · Cited by 53
Type I IFN drives unconventional IL-1β secretion in lupus monocytes
Caielli, S., Balasubramanian, P., Rodríguez-Alcázar, J. F., Balaji, U., Robinson, L. A., Wan, Z., Baisch, J. M., Smitherman, C., Walters, L., Sparagana, P. R., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.004 · Cited by 58
TNF- α potentiates uric acid-induced interleukin-1 β (IL-1 β ) secretion in human neutrophils
Yokose, K., Sato, S., Asano, T., Yashiro, M., Kobayashi, H., Watanabe, H., Suzuki, E., Sato, C., Kozuru, H., Yatsuhashi, H., et al. (2017) · Modern Rheumatology · doi:10.1080/14397595.2017.1369924 · Cited by 54
Wu, H., Liu, X., Gao, Z., Lin, M. S., Zhao, X. S., Sun, Y. X., & Pu, X. (2021) · Antioxidants · doi:10.3390/antiox10040529 · Cited by 53
NLRP3 Inflammasome Participates in Host Response to Neospora caninum Infection
Wang, X., Gong, P., Zhang, X., Li, S., Lu, X.-Y., Zhao, C., Yu, Q., Wei, Z., Yang, Y., Liu, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01791 · Cited by 51
Jin, J., Lv, X., Wang, B., Ren, C., Jiang, J., Chen, H., Chen, X., Gu, M., Pan, Z., Tian, N., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7292512 · Cited by 50
COPs and POPs Patrol Inflammasome Activation
Indramohan, M., Stehlik, C., & Dorfleutner, A. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.10.004 · Cited by 49
Wang, Y., Sui, Z., Wang, M., & Liu, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196016 · Cited by 49
Botto, S., Abraham, J., Mizuno, N., Pryke, K. M., Gall, B., Landais, I., Streblow, D. N., Früh, K., & DeFilippis, V. R. (2019) · mBio · doi:10.1128/mbio.02510-18 · Cited by 48
D’Espessailles, A., Mora, Y. A., Fuentes, C., & Cifuentes, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26490 · Cited by 46
Ye, A., Li, W., Zhou, L., Ao, L., Fang, W., & Li, Y. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.10.009 · Cited by 46
Triantafilou, K., Ward, C. J. K., Czubala, M. A., Ferris, R. G., Koppe, E. L., Haffner, C. D., Piguet, V., Patel, V. K., Amrine‐Madsen, H., Modis, L. K., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009417 · Cited by 45
Self-citationNLRP3 in somatic non-immune cells of rodent and primate testes
Walenta, L., Schmid, N., Schwarzer, J., Köhn, F., Urbanski, H. F., Behr, R., Strauss, L., POUTANEN, M. H., & Mayerhofer, A. (2018) · Reproduction · doi:10.1530/rep-18-0111 · Cited by 45
Rahman, K., & Fisher, E. A. A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00032 · Cited by 48
Effects of phosphorylation on the NLRP3 inflammasome
Sandall, C. F., & MacDonald, J. A. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.02.020 · Cited by 44
Zhang, L., Lu, L., Zhong, X., Yue, Y., Hong, Y., Li, Y., & Li, Y. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.006 · Cited by 44
Sousa, C., Leitão, A. J., Neves, B. M., Judas, F., Cavaleiro, C., & Mendes, A. F. (2020) · Scientific Reports · doi:10.1038/s41598-020-64032-1 · Cited by 43
Zhou, P., Dai, J., Zhang, K., Wang, T., Li, L., Luo, Y., Sun, Y., Qiu, H., & Li, S. (2022) · Journal of Virology · doi:10.1128/jvi.00954-22 · Cited by 42
Jia, K., Ding, H., Yu, H., Dong, T., Pan, Y., & Kong, L. (2018) · Mediators of Inflammation · doi:10.1155/2018/3093516 · Cited by 43
NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity
Sokolova, M., Sjaastad, I., Louwe, M. C., Alfsnes, K., Aronsen, J. M., Zhang, L., Haugstad, S. B., Bendiksen, B. A., Øgaard, J., Bliksøen, M., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01621 · Cited by 42
Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome
Pizzuto, M., Pelegrín, P., & Ruysschaert, J. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101182 · Cited by 44
Atherosclerosis and Its Related Laboratory Biomarkers
Corte, V. D., Todaro, F., Cataldi, M., & Tuttolomondo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115546 · Cited by 41
Bao, J., Sun, T., Yue, Y., & Xiong, S. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.07.012 · Cited by 41
Sokolova, M., Yang, K., Hansen, S. H., Louwe, M. C., Kummen, M., Hov, J. R., Sjaastad, I., Berge, R. K., Halvorsen, B. L., Aukrust, P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76497-1 · Cited by 39
Zhou, L., Huang, W. G., Xu, Y., Gao, C., Zhang, T., Guo, M., Liu, Y., Ding, J., Qin, L., Xu, Z., et al. (2018) · Journal of Diabetes Research · doi:10.1155/2018/7078214 · Cited by 38
Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity
Bertinaria, M., Gastaldi, S., Marini, E., & Giorgis, M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.11.013 · Cited by 38
Sartoretto, S. C., Piperni, S. G., da Silva, R. A., Calasans‐Maia, M. D., Rucci, N., dos Santos, T. M. P., Lima, I., Rossi, A. M., Alves, G. G., Granjeiro, J. M., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27226 · Cited by 35
The NLRP1 inflammasome in skin diseases
Burian, M., Schmidt, M. F., & Yazdi, A. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111611 · Cited by 35
Podocyte NADPH Oxidase 5 Promotes Renal Inflammation Regulated by the Toll-Like Receptor Pathway
Holterman, C. E., Boisvert, N. C., Thibodeau, J.-F., Kamto, E., Novakovic, M., Abd‐Elrahman, K. S., Ferguson, S. S. G., & Kennedy, C. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7402 · Cited by 34
Öörni, K., & Kovanen, P. T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081769 · Cited by 35
Diaz-del-Olmo, I., Worboys, J. D., Martín‐Sánchez, F., Gritsenko, A., Ambrose, A. R., Tannahill, G. M., Nichols, E.-M., López‐Castejón, G., & Davis, D. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720655 · Cited by 37
Sun, L., Yuan, H., & Zhao, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-22617-y · Cited by 32
He, X., Li, C., Yin, H., Tan, X., Yi, J., Tian, S., Wang, Y., & Liu, J. (2022) · Bioengineered · doi:10.1080/21655979.2022.2052652 · Cited by 33
Ferko, M.-A., & Catelas, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199936 · Cited by 33
Xu, K., Tong, S., Wu, C., Ding, X., Chen, J.-L., Yu, M., & Wang, S. (2020) · Transplantation · doi:10.1097/tp.0000000000003208 · Cited by 33
Li, L., Wang, X., Gong, P., Zhang, N., Zhang, X., Li, S., Li, X., Liu, S.-X., Zhang, X.-X., Li, W., et al. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04331-8 · Cited by 33
Fenini, G., Karakaya, T., Hennig, P., Filippo, M. D., Slaufova, M., & Beer, H. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.04.004 · Cited by 35
Inflammasome activation by Gram-positive bacteria: Mechanisms of activation and regulation
Keestra-Gounder, A. M., & Nagao, P. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1075834 · Cited by 33
Role of toll-like receptor-mediated pyroptosis in sepsis-induced cardiomyopathy
Fan, Y., Guan, B., Xu, J., Zhang, H., Liang, Y., & Yang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115493 · Cited by 35
Sun, Y. J., Huang, W.-M., Tang, P.-C., Zhang, X., Zhang, X.-Y., Yu, B.-C., Fan, Y. M., Ge, X., & Zhang, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104274 · Cited by 33
Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
Thapa, P., Upadhyay, S. P., Singh, V., Boinpelly, V. C., Zhou, J., Johnson, D. K., Gurung, P., Lee, E. S., Sharma, R., & Sharma, M. (2022) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2022.100100 · Cited by 32
Metadata
- Authors
- Patel, M. N., Carroll, R. G., Galván-Peña, S., Mills, E. L., Olden, R., Triantafilou, M., Wolf, A. I., Bryant, C. E., Triantafilou, K., & Masters, S. L.
- Affiliations
- GlaxoSmithKline (United Kingdom) (GB)
- GlaxoSmithKline (United States) (US)
- The University of Melbourne (AU)
- Corresponding author
- Masters, Seth L.
- ORCID
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 23
- Issue
- 2
- Pages
- 165-180
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W2572287198
- Cited by
- 241
- References
- 153
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 15 · 2023: 24 · 2022: 29 · 2021: 25 · 2020: 37 · 2019: 31 · 2018: 33 · 2017: 17
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- inflammasome priming, sterile inflammation, NLRP3 inflammasome, caspase-11, IL-1β processing, IL-18, pyroptosis, post-translational modification, atherosclerosis, metabolic disorders, neuroinflammation, Toll-like receptor ligands
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Animals, Humans, Immunity, Innate, Inflammation, Metabolic Diseases, Obesity, Neuroimmunomodulation, Atherosclerosis, Toll-Like Receptors, Interleukin-1beta, Hereditary Autoinflammatory Diseases, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review